List of Tables
    Table 1. Breakthrough Therapy (BT) Designation Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Breakthrough Therapy (BT) Designation Market Trends
    Table 3. Breakthrough Therapy (BT) Designation Market Drivers
    Table 4. Breakthrough Therapy (BT) Designation Market Challenges
    Table 5. Breakthrough Therapy (BT) Designation Market Restraints
    Table 6. Global Breakthrough Therapy (BT) Designation Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Breakthrough Therapy (BT) Designation Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Breakthrough Therapy (BT) Designation Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Breakthrough Therapy (BT) Designation Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Breakthrough Therapy (BT) Designation Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Breakthrough Therapy (BT) Designation Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Breakthrough Therapy (BT) Designation Revenue Share by Player, 2017-2022
    Table 13. Global Breakthrough Therapy (BT) Designation Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Breakthrough Therapy (BT) Designation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breakthrough Therapy (BT) Designation as of 2021)
    Table 15. Top Players of Breakthrough Therapy (BT) Designation in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Breakthrough Therapy (BT) Designation Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Breakthrough Therapy (BT) Designation Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Breakthrough Therapy (BT) Designation Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Breakthrough Therapy (BT) Designation Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Breakthrough Therapy (BT) Designation Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Breakthrough Therapy (BT) Designation Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Breakthrough Therapy (BT) Designation Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Breakthrough Therapy (BT) Designation Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Breakthrough Therapy (BT) Designation Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Breakthrough Therapy (BT) Designation Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Breakthrough Therapy (BT) Designation Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Breakthrough Therapy (BT) Designation Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Roche Company Details
    Table 31. Roche Business Overview
    Table 32. Roche Breakthrough Therapy (BT) Designation Product
    Table 33. Roche Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 34. Roche Recent Development
    Table 35. Abbvie Company Details
    Table 36. Abbvie Business Overview
    Table 37. Abbvie Breakthrough Therapy (BT) Designation Product
    Table 38. Abbvie Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 39. Abbvie Recent Development
    Table 40. Novartis International AG Company Details
    Table 41. Novartis International AG Business Overview
    Table 42. Novartis International AG Breakthrough Therapy (BT) Designation Product
    Table 43. Novartis International AG Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 44. Novartis International AG Recent Development
    Table 45. Janssen Company Details
    Table 46. Janssen Business Overview
    Table 47. Janssen Breakthrough Therapy (BT) Designation Product
    Table 48. Janssen Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 49. Janssen Recent Development
    Table 50. BMS Company Details
    Table 51. BMS Business Overview
    Table 52. BMS Breakthrough Therapy (BT) Designation Product
    Table 53. BMS Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 54. BMS Recent Development
    Table 55. Eli Lilly Company Details
    Table 56. Eli Lilly Business Overview
    Table 57. Eli Lilly Breakthrough Therapy (BT) Designation Product
    Table 58. Eli Lilly Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 59. Eli Lilly Recent Development
    Table 60. Gilead Company Details
    Table 61. Gilead Business Overview
    Table 62. Gilead Breakthrough Therapy (BT) Designation Product
    Table 63. Gilead Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 64. Gilead Recent Development
    Table 65. Sanofi Company Details
    Table 66. Sanofi Business Overview
    Table 67. Sanofi Breakthrough Therapy (BT) Designation Product
    Table 68. Sanofi Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 69. Sanofi Recent Development
    Table 70. Regeneron Company Details
    Table 71. Regeneron Business Overview
    Table 72. Regeneron Breakthrough Therapy (BT) Designation Product
    Table 73. Regeneron Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 74. Regeneron Recent Development
    Table 75. Acadia Company Details
    Table 76. Acadia Business Overview
    Table 77. Acadia Breakthrough Therapy (BT) Designation Product
    Table 78. Acadia Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 79. Acadia Recent Development
    Table 80. Boehringer Ingelheim Company Details
    Table 81. Boehringer Ingelheim Business Overview
    Table 82. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Product
    Table 83. Boehringer Ingelheim Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 84. Boehringer Ingelheim Recent Development
    Table 85. Amgen Company Details
    Table 86. Amgen Business Overview
    Table 87. Amgen Breakthrough Therapy (BT) Designation Product
    Table 88. Amgen Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 89. Amgen Recent Development
    Table 90. AstraZeneca Company Details
    Table 91. AstraZeneca Business Overview
    Table 92. AstraZeneca Breakthrough Therapy (BT) Designation Product
    Table 93. AstraZeneca Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 94. AstraZeneca Recent Development
    Table 95. GlaxoSmithKline Company Details
    Table 96. GlaxoSmithKline Business Overview
    Table 97. GlaxoSmithKline Breakthrough Therapy (BT) Designation Product
    Table 98. GlaxoSmithKline Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 99. GlaxoSmithKline Recent Development
    Table 100. Vertex Company Details
    Table 101. Vertex Business Overview
    Table 102. Vertex Breakthrough Therapy (BT) Designation Product
    Table 103. Vertex Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 104. Vertex Recent Development
    Table 105. Alexion Company Details
    Table 106. Alexion Business Overview
    Table 107. Alexion Breakthrough Therapy (BT) Designation Product
    Table 108. Alexion Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 109. Alexion Recent Development
    Table 110. Merck Company Details
    Table 111. Merck Business Overview
    Table 112. Merck Breakthrough Therapy (BT) Designation Product
    Table 113. Merck Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 114. Merck Recent Development
    Table 115. Jazz Pharmaceuticals Company Details
    Table 116. Jazz Pharmaceuticals Business Overview
    Table 117. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Product
    Table 118. Jazz Pharmaceuticals Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 119. Jazz Pharmaceuticals Recent Development
    Table 120. Exelixis Company Details
    Table 121. Exelixis Business Overview
    Table 122. Exelixis Breakthrough Therapy (BT) Designation Product
    Table 123. Exelixis Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 124. Exelixis Recent Development
    Table 125. Eisai Company Details
    Table 126. Eisai Business Overview
    Table 127. Eisai Breakthrough Therapy (BT) Designation Product
    Table 128. Eisai Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 129. Eisai Recent Development
    Table 130. Takeda Company Details
    Table 131. Takeda Business Overview
    Table 132. Takeda Breakthrough Therapy (BT) Designation Product
    Table 133. Takeda Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 134. Takeda Recent Development
    Table 135. Pfizer Company Details
    Table 136. Pfizer Business Overview
    Table 137. Pfizer Breakthrough Therapy (BT) Designation Product
    Table 138. Pfizer Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 139. Pfizer Recent Development
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Breakthrough Therapy (BT) Designation Product Picture
    Figure 2. Global Breakthrough Therapy (BT) Designation Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Breakthrough Therapy (BT) Designation Market Size 2017-2028 (US$ Million)
    Figure 4. United States Breakthrough Therapy (BT) Designation Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Breakthrough Therapy (BT) Designation Market Size 2017-2028 (US$ Million)
    Figure 6. United States Breakthrough Therapy (BT) Designation Market Share in Global 2017-2028
    Figure 7. Breakthrough Therapy (BT) Designation Report Years Considered
    Figure 8. Product Picture of Oncology
    Figure 9. Product Picture of Infectious Diseases
    Figure 10. Product Picture of Rare Diseases
    Figure 11. Product Picture of Autoimmune Diseases
    Figure 12. Product Picture of Pulmonary Diseases
    Figure 13. Product Picture of Neurological Disorders
    Figure 14. Product Picture of Others
    Figure 15. Global Breakthrough Therapy (BT) Designation Market Share by Type in 2022 & 2028
    Figure 16. Global Breakthrough Therapy (BT) Designation Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. Global Breakthrough Therapy (BT) Designation Market Share by Type (2017-2028)
    Figure 18. United States Breakthrough Therapy (BT) Designation Market Share by Type in 2022 & 2028
    Figure 19. United States Breakthrough Therapy (BT) Designation Market Size by Type (2017-2028) & (US$ Million)
    Figure 20. United States Breakthrough Therapy (BT) Designation Market Share by Type (2017-2028)
    Figure 21. Product Picture of Hospital
    Figure 22. Product Picture of Clinic
    Figure 23. Product Picture of Research Institute
    Figure 24. Product Picture of Laboratories
    Figure 25. Product Picture of Others
    Figure 26. Global Breakthrough Therapy (BT) Designation Market Share by Application in 2022 & 2028
    Figure 27. Global Breakthrough Therapy (BT) Designation Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. Global Breakthrough Therapy (BT) Designation Market Share by Application (2017-2028)
    Figure 29. United States Breakthrough Therapy (BT) Designation Market Share by Application in 2022 & 2028
    Figure 30. United States Breakthrough Therapy (BT) Designation Market Size by Application (2017-2028) & (US$ Million)
    Figure 31. United States Breakthrough Therapy (BT) Designation Market Share by Application (2017-2028)
    Figure 32. North America Breakthrough Therapy (BT) Designation Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. U.S. Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Canada Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Europe Breakthrough Therapy (BT) Designation Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. Germany Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. France Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. U.K. Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Italy Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Russia Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Asia-Pacific Breakthrough Therapy (BT) Designation Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 42. China Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Japan Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. South Korea Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. India Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Australia Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Taiwan Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Indonesia Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Thailand Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Malaysia Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Philippines Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Latin America Breakthrough Therapy (BT) Designation Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Mexico Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Brazil Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Argentina Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Middle East & Africa Breakthrough Therapy (BT) Designation Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 57. Turkey Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Saudi Arabia Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 59. U.A.E Breakthrough Therapy (BT) Designation Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Roche Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 61. Abbvie Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 62. Novartis International AG Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 63. Janssen Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 64. BMS Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 65. Eli Lilly Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 66. Gilead Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 67. Sanofi Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 68. Regeneron Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 69. Acadia Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 70. Boehringer Ingelheim Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 71. Amgen Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 72. AstraZeneca Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 73. GlaxoSmithKline Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 74. Vertex Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 75. Alexion Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 76. Merck Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 77. Jazz Pharmaceuticals Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 78. Exelixis Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 79. Eisai Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 80. Takeda Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 81. Pfizer Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed